Cancer

Nuclear Medicine Equipment Market to Reach $16.1 billion, Globally, by 2033 at 11.3% CAGR: Allied Market Research

Surge in the prevalence of chronic diseases such as cancer & cardiovascular diseases and advancements in technology drive the growth…

35 minutes ago

Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna has requested a Type…

36 minutes ago

Tissue Diagnostics Market worth $10.86 billion by 2030 | MarketsandMarkets™

DELRAY BEACH, Fla., Feb. 10, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Tissue Diagnostics Market is projected to grow from about…

7 hours ago

SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems

BOSTON and ROLLE, Switzerland, Feb. 10, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today…

7 hours ago

/C O R R E C T I O N — Conexiant/

In the news release, ASCO and Conexiant Launch ASCO AI in Oncology, a Premium Digital Destination Connecting Brands with Oncology…

7 hours ago

Leading Board-Certified Plastic Surgeon Dr. David W. Allison Moves to New Princeton Location on Bunn Drive

Experienced plastic surgeon relocates to Princeton, offering face, breast, body, and reconstructive procedures. PRINCETON, NEW JERSEY / ACCESS Newswire /…

7 hours ago

FibroBiologics’ Chairman & CEO Pete O’Heeron Selected to Present at A4LI’s H-SPAN Summit at Georgetown University

HOUSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with…

9 hours ago

RenovoRx Establishes RenovoCath® Medical Advisory Board

Advisory Board Members Will Provide Strategic Clinical Insights to Further Advance the TAMP™ Therapy Platform in Clinical Indications of High…

9 hours ago

Oncotelic Therapeutics, Inc. Showcases Multi-Year Execution and Validation, Enters 2026 with Late-Stage Momentum Across Diversified Pipeline

AGOURA HILLS, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- via IBN — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the…

9 hours ago

Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026

BRISBANE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical…

9 hours ago